KNOX PHARMACEUTICALS LIMITED
- Legal registered address
- Unit 2 Barugh Way, Barker Business Park, Melmerby Ripon England HG4 5NG
Latest financial results as of 31 October 2022- Cash in bank
- £1.68m
- Current assets
- £7.06m
- Current creditors
- £2.65m
- Shareholders funds
- £5.30m
View full financial accounts- Cash in bank
- £1.68m
- Current assets
- £7.06m
- Current creditors
- £2.65m
- Shareholders funds
- £5.30m
Analysis from latest company accounts
Based on the provided company accounts, here are some key points and conclusions about Knox Pharmaceuticals Limited:
1. Turnover: Knox Pharmaceuticals Limited has experienced an increase in sales, with turnover increasing from £19,312,482 in 2021 to £23,230,125 in 2022.
... View full analysis
- Company number
- 03047023
Accounts
Latest annual accounts were to 31 October 2022
Next annual accounts are due by 31 July 2024
Company financial year end is on 31 October 2024
Confirmation statement
Latest confirmation statement statement dated 18 April 2023
Next statement due by 2 May 2024
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Latest company documents
Date | Description |
---|---|
27/07/2327 July 2023 | Full accounts made up to 2022-10-31 |
20/04/2320 April 2023 | Confirmation statement made on 2023-04-18 with no updates |
31/10/2231 October 2022 | Annual accounts for year ending 31 Oct 2022Analyse these accounts |
22/04/2222 April 2022 | Confirmation statement made on 2022-04-18 with no updates |
19/11/2119 November 2021 | Notification of Knox Holdings Limited as a person with significant control on 2021-11-08 |
More Company Information
- Company overview
- All company documents and filing history
- People connected with this company
- Financial details of KNOX PHARMACEUTICALS LIMITED
- Who controls this company?
- Charges and Mortgages registered against company
- The Company's website
- Location, contact details and map
- Related companies and people
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company